MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
An Interview With Mark W. Mewissen, MD
A renowned vascular radiologist shares his wisdom about the state of the practice, SFA stenting, and online education.
By Mark W. Mewissen, MD
Stenting in Long, Complex Lesions Is Superior to the “Old Standard”
Endograft Treatment in the SFA
Current SFA stent graft technology has overcome early shortcomings and carries the potential to become the standard of care in selected patients.
Nitinol Stents in the Femoropopliteal Arterial Segment
One center's experience with the Cordis SMART stent suggests the device should play a larger role in treating this vessel.
Sponsored by Medtronic
Meet the Challenge: Aortic Center Strategic Planning, Investments, and Tactics
By John R. Doty, MD; Brad Kruger, MBA; Eric S. Weiss, MD, MPH; Mark W. Mewissen, MD; Chantay Coulter, RN; and Tom Draper, MBA
Aggressive DVT Management Strategies and Techniques
Experts share their experiences with early intervention using pharmacomechanical thrombectomy and temporary filter placement, which have shown rapid symptom resolution and encouraging outcomes.
By Mark W. Mewissen, MD; Anthony C. Venbrux, MD; and Peter H. Lin, MD
Sponsored by Iatri Devices
The Telescoping Advantage: A New Era in Peripheral CTO Crossing With the BOSScsc System
With Mark W. Mewissen, MD, FSIR, FSVM, RVT; Brian Brown, MD; and John W. Davis III, MD
Expanding the Role of Peripheral Endografts
By John R. Laird, Jr, MD, Chief Medical Editor
The VIBRANT Trial
Comparing bare-nitinol stents to stent grafts in long superficial femoral artery lesions in this unique trial.
By Gary M. Ansel, MD, FACC; Patrick J. Geraghty, MD, FACS; Mark Mewissen, MD; and Michael R. Jaff, DO
A Tale of Two Legs: Putting Patients Ahead by Leaving Nothing Behind
By Gregory A. Stanley, MD
Long Nitinol Stenting in the Femoropopliteal System
Unintended consequences of nitinol stenting on endovascular treatment of the superficial femoral and popliteal arteries.
By Frank J. Arena, MD, FACC, FSCAI
An Interview With Gary Ansel, MD
A top interventional cardiologist shares his insight on the future of SFA treatment and what to expect from VIVA 2005.
By Gary Ansel, MD
Covered Stents in Longer Lesions
Peter A. Soukas, MD, discusses the available data, his clinical experiences, and techniques for better outcomes and restenosis prevention.
